Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

SPY
President Trump Says Will Be Naming AI Czar In Next Three Or Four Days

President Trump Says Will Be Naming AI Czar In Next Three Or Four Days...

CRM
Salesforce Announces Deal To Acquire AI Customer Research Platform Listen Labs; Terms Not Disclosed, Expects Close In Fiscal Q4 2027

Salesforce Announces Deal To Acquire AI Customer Research Platform Listen Labs; Terms Not Disclosed, Expects Close In Fiscal Q4 2027...

MSFT
Microsoft Brings OpenAI’s Autonomous ‘Dots’ AI Workers Into the Enterprise

Microsoft Brings OpenAI’s Autonomous ‘Dots’ AI Workers Into the Enterprise...

ARKK
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You

Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You...

AMZN
'Anthropic IPO prospectus lays bare deep dependence on Big Tech partners; Sales through Amazon and Google were $2.16B in 2025, filing seen by Reuters shows'- Reuters Exclusive

'Anthropic IPO prospectus lays bare deep dependence on Big Tech partners; Sales through Amazon and Google were $2.16B in 2025, filing seen by Reuters...

META
Meta’s Muse Has Found Apple’s Weak Spot, Bank of America Warns

Meta’s Muse Has Found Apple’s Weak Spot, Bank of America Warns...

BA
'Boeing wins Navy next-gen fighter F/A-XX competition'- Breaking Defense

'Boeing wins Navy next-gen fighter F/A-XX competition'- Breaking Defense...

UNH
Here's How Much $100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth Today

Here's How Much $100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth Today...

V
If You Invested $1000 In Visa Stock 15 Years Ago, You Would Have This Much Today

If You Invested $1000 In Visa Stock 15 Years Ago, You Would Have This Much Today...

ZYDUS
FDA Approves Unknown Drug — ZYDUS LIFESCIENCES

FDA has granted approval to Zydus Lifesciences under ANDA 218361, paving the way for the manufacturer to potentially enter a new market segment and ch...

FDA
FDA approves first treatment for MCT8 Deficiency

The U.S. FDA has approved Emcitate (tiratricol) to treat peripheral thyrotoxicosis, the first FDA-approved therapy for MCT8 Deficiency. The condition ...

FDA
FDA reviewing PMTA rules after Texas court challenge

FDA is carefully reviewing its Premarket Tobacco Product Application rule and judicial developments, including a federal lawsuit filed in the Northern...

Quantum-Si
Quantum-Si Updates Prototypes at World HUPO 2026

Quantum-Si presented data and updates for the ProteusTM single-molecule protein sequencing platform at the World HUPO 2026 conference. The filing high...

NEWS
News Corp announces buyback program of US$1 billion

News Corporation has announced a buyback of its Class A Common Stock for up to US$1 billion. The company filed an Appendix 3C notification with ASX....

NETSOL
NETSOL Technologies Posts Record Q4 Revenue And Full-Year Profit

NETSOL Technologies reported record fiscal 2026 revenue and profitability; the company provided fiscal 2027 guidance....

Prospect
Prospect Fund Raises 14.46% Annualized Distribution Rate in September

Prospect Floating Rate and Alternative Income Fund declared a monthly base cash distribution of $0.03242 and a quarterly bonus of $0.04333 per share f...

BRILLIANT
Origin Tea, Inc. CEO Tests to SEC

Boladale Lawal & Co. CEO signed a letter of agreement with the SEC supporting Origin Tea's regulatory filing, highlighting the company's corporate gov...

Glucotrack,
Glucotrack amends warrant for Nasdaq compliance

Glucotrack amended a warrant to include a 20% floor price for share purchases relative to Nasdaq requirements. This change aims to protect the holder ...

Polar
Polar Power exchanges notes for stock and warrants

Polar Power agreed to exchange $614,700 in notes for $747,874 of preferred stock and warrants, reducing outstanding debt obligations. This corporate a...

AST
AST SpaceMobile updates Change of Control severance policy

The company amended its Senior Management Change of Control Severance Policy to cover additional executive roles and standardize severance eligibility...